A Case Report of Intravitreal Aflibercept for Iris Metastasis from Small Cell Lung Carcinoma with Neovascular Glaucoma
This is the first reported use of intravitreal aflibercept for SCLC metastases to the iris. While the prognosis of patients with metastatic iris tumors remains poor, intravitreal aflibercept injections show potential in reducing iris tumor size and lowering IOP. Although not curative, this therapeutic approach may play a significant role in the symptom management of these patients.
Authors
- Midori Goto
- Junko Hori (ORCID: https://orcid.org/0000-0002-4248-5742)
- Kenji Nakamoto (ORCID: https://orcid.org/0000-0001-9805-2359)
- Fumiki Okamoto (ORCID: https://orcid.org/0000-0001-6164-7164)
- K Hirakata
Institutions
- Nippon Medical School (JP)
Publication Details
- Journal
- Case Reports in Ophthalmology
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1159/000544159
- Citations
- 1
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71